374 related articles for article (PubMed ID: 17274819)
21. Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors.
Iczkowski KA; Butler SL; Shanks JH; Hossain D; Schall A; Meiers I; Zhou M; Torkko KC; Kim SJ; MacLennan GT
Hum Pathol; 2008 Feb; 39(2):275-81. PubMed ID: 18045648
[TBL] [Abstract][Full Text] [Related]
22. An oncofetal and developmental perspective on testicular germ cell cancer.
Rijlaarsdam MA; Looijenga LH
Semin Cancer Biol; 2014 Dec; 29():59-74. PubMed ID: 25066859
[TBL] [Abstract][Full Text] [Related]
23. Undifferentiated gonadal tissue, Y chromosome instability, and tumors in XY gonadal dysgenesis.
Beaulieu Bergeron M; Lemieux N; Brochu P
Pediatr Dev Pathol; 2011; 14(6):445-59. PubMed ID: 21692598
[TBL] [Abstract][Full Text] [Related]
24. Progenitor stem cell marker expression by pulmonary carcinomas.
Moreira AL; Gonen M; Rekhtman N; Downey RJ
Mod Pathol; 2010 Jun; 23(6):889-95. PubMed ID: 20305619
[TBL] [Abstract][Full Text] [Related]
25. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
[TBL] [Abstract][Full Text] [Related]
26. OCT4: a novel biomarker for dysgerminoma of the ovary.
Cheng L; Thomas A; Roth LM; Zheng W; Michael H; Karim FW
Am J Surg Pathol; 2004 Oct; 28(10):1341-6. PubMed ID: 15371950
[TBL] [Abstract][Full Text] [Related]
27. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
28. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
Santagata S; Ligon KL; Hornick JL
Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
[TBL] [Abstract][Full Text] [Related]
29. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.
Looijenga LH; Stoop H; de Leeuw HP; de Gouveia Brazao CA; Gillis AJ; van Roozendaal KE; van Zoelen EJ; Weber RF; Wolffenbuttel KP; van Dekken H; Honecker F; Bokemeyer C; Perlman EJ; Schneider DT; Kononen J; Sauter G; Oosterhuis JW
Cancer Res; 2003 May; 63(9):2244-50. PubMed ID: 12727846
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
[TBL] [Abstract][Full Text] [Related]
31. KIT gene mutation and amplification in dysgerminoma of the ovary.
Cheng L; Roth LM; Zhang S; Wang M; Morton MJ; Zheng W; Abdul Karim FW; Montironi R; Lopez-Beltran A
Cancer; 2011 May; 117(10):2096-103. PubMed ID: 21523721
[TBL] [Abstract][Full Text] [Related]
32. Canine ovarian gonadoblastoma with dysgerminoma overgrowth: a case study and literature review.
Flores AR; Lobo J; Nunes F; Rêma A; Lopes P; Carvalho L; Bartosch C; Amorim I; Gärtner F
J Ovarian Res; 2019 Sep; 12(1):89. PubMed ID: 31547830
[TBL] [Abstract][Full Text] [Related]
33. Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors.
Chang MC; Vargas SO; Hornick JL; Hirsch MS; Crum CP; Nucci MR
Int J Gynecol Pathol; 2009 Jul; 28(4):347-55. PubMed ID: 19483629
[TBL] [Abstract][Full Text] [Related]
34. Predicting Gonadal Germ Cell Cancer in People with Disorders of Sex Development; Insights from Developmental Biology.
Looijenga LHJ; Kao CS; Idrees MT
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31658757
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of pluripotent and germ cell markers in ovarian surface epithelium according to age in female mice.
Joo BS; Jung IK; Park MJ; Joo JK; Kim KH; Lee KS
Reprod Biol Endocrinol; 2014 Nov; 12():113. PubMed ID: 25421381
[TBL] [Abstract][Full Text] [Related]
36. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells.
Honecker F; Stoop H; de Krijger RR; Chris Lau YF; Bokemeyer C; Looijenga LH
J Pathol; 2004 Jul; 203(3):849-57. PubMed ID: 15221945
[TBL] [Abstract][Full Text] [Related]
37. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development.
Skotheim RI; Lind GE; Monni O; Nesland JM; Abeler VM; Fosså SD; Duale N; Brunborg G; Kallioniemi O; Andrews PW; Lothe RA
Cancer Res; 2005 Jul; 65(13):5588-98. PubMed ID: 15994931
[TBL] [Abstract][Full Text] [Related]
38. Gonadoblastoma with contralateral dysgerminoma in a young female--a case report.
Jadhav MN; Yelikar BR; Karigoudar M
Indian J Pathol Microbiol; 2006 Apr; 49(2):274-6. PubMed ID: 16933739
[TBL] [Abstract][Full Text] [Related]
39. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.
Cheng L; Sung MT; Cossu-Rocca P; Jones TD; MacLennan GT; De Jong J; Lopez-Beltran A; Montironi R; Looijenga LH
J Pathol; 2007 Jan; 211(1):1-9. PubMed ID: 17117392
[TBL] [Abstract][Full Text] [Related]
40. Stem cell research points the way to the cell of origin for intracranial germ cell tumours.
Tan C; Scotting PJ
J Pathol; 2013 Jan; 229(1):4-11. PubMed ID: 22926997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]